HS Code 30019099 — Other glands, organs and substances of human/animal origin
Chapter 30 (Pharmaceutical Products) · Heading 3001 (Glands and organs for organo-therapeutic uses; extracts thereof) · Last updated: March 2026 · Source: Indian Customs (DGFT) Records
HS Code 30019099 (Other glands, organs and substances of human/animal origin) is one of India's most significant pharmaceutical export classifications under Chapter 30 of the Harmonized System. With a total trade value of $10.7M across 456 shipments, this code covers 11 distinct pharmaceutical products exported by 43 Indian manufacturers to 53 countries. The leading product under this classification is Heparin at $4.1M, followed by Sodium and Chondroitin.
The top importing markets include United States, Saudi Arabia, Thailand. The top 5 products account for 95.2% of total trade under this code. Average transaction value is $23.4K. Leading exporters include SANOFI-AVENTIS SINGAPORE PTE LTD and PFIZER SERVICE COMPANY BV. Data sourced from Indian Customs (DGFT) shipping bill records.
Products Exported Under HS Code 30019099
11 pharmaceutical products classified under this code, ranked by trade value
| Rank | Product | Trade Value | Transactions | Avg Price | Suppliers |
|---|---|---|---|---|---|
| #1 | Heparin | $4.1M | 87 | $50989.47 | 57 |
| #2 | Sodium | $3.4M | 47 | $282652.57 | 25 |
| #3 | Chondroitin | $1.7M | 24 | $47.09 | 13 |
| #4 | Enoxaparin | $527.7K | 170 | $18886.03 | 36 |
| #5 | Antitoxin | $467.0K | 1 | $849.16 | 1 |
| #6 | Collagen | $375.7K | 118 | $133.33 | 2 |
| #7 | Phenylephrine | $82.1K | 1 | $5.47 | 1 |
| #8 | Amikacin | $30.8K | 1 | $65.43 | 1 |
| #9 | Extract | $25.1K | 3 | $66.66 | 2 |
| #10 | Bevacizumab | $2.5K | 2 | $81.70 | 2 |
| #11 | Carvedilol | $222 | 2 | $1.09 | 1 |
Import Destinations — HS Code 30019099
53 countries import products classified under HS Code 30019099 from India
Indian pharmaceutical exports under HS Code 30019099 reach 53 countries worldwide. The largest importer is United States ($504.3M), followed by Saudi Arabia ($89.7M), Thailand ($40.2M), Russia ($34.2M). This geographic spread reflects India's position as the world's largest supplier of generic pharmaceutical products by volume.
| Rank | Country | Trade Value | Market Share |
|---|---|---|---|
| #1 | United States | $504.3M | 4727.1% |
| #2 | Saudi Arabia | $89.7M | 840.3% |
| #3 | Thailand | $40.2M | 377.2% |
| #4 | Russia | $34.2M | 320.7% |
| #5 | Guatemala | $31.6M | 296.0% |
| #6 | Philippines | $18.6M | 174.0% |
| #7 | Canada | $16.3M | 152.9% |
| #8 | France | $16.3M | 152.7% |
| #9 | Ecuador | $16.2M | 151.9% |
| #10 | Peru | $15.9M | 148.9% |
| #11 | Sri Lanka | $13.6M | 127.5% |
| #12 | Brazil | $13.3M | 124.5% |
| #13 | Chile | $11.2M | 104.9% |
| #14 | Tanzania | $10.0M | 93.9% |
| #15 | Australia | $9.8M | 91.8% |
Top Indian Exporters — HS Code 30019099
43 Indian pharmaceutical manufacturers export under this classification
Understanding HS Code 30019099
The Harmonized System (HS) is an internationally standardized system of names and numbers to classify traded products, used by over 200 countries for customs tariffs and trade statistics. HS Code 30019099 is an 8-digit Indian Customs Tariff (ITC-HS) code that precisely identifies products classified as "Other glands, organs and substances of human/animal origin".
Code Structure Breakdown
The first 6 digits (300190) are standardized by the World Customs Organization (WCO) and used identically across all 200+ member countries. Digits 7-8 are India-specific subdivisions defined by the Directorate General of Foreign Trade (DGFT) for more granular classification of pharmaceutical exports. This code is declared on every shipping bill filed with Indian Customs for products matching this classification.
Regulatory & Compliance — HS Code 30019099
Correct classification under HS Code 30019099 is critical for customs clearance, duty assessment, and regulatory compliance. Misclassification can result in shipment delays, incorrect duty payments, and penalties from customs authorities.
Import Duty Rates
As a Chapter 30 pharmaceutical product, HS Code 30019099 may qualify for preferential duty rates in many markets. WTO TRIPS provisions and bilateral FTAs (e.g., India-ASEAN, India-Japan CEPA) can significantly reduce applicable duties.
DGFT Export Requirements
Indian exporters must declare HS Code 30019099 on shipping bills filed with DGFT. Pharmaceutical exports require Drug Controller General of India (DCGI) approval, Certificate of Pharmaceutical Product (COPP), and compliance with the Drugs & Cosmetics Act.
WHO Prequalification
Products under this code destined for international procurement programs (UNICEF, Global Fund, PEPFAR) typically require WHO Prequalification. PQ status affects eligibility for preferential procurement and duty exemptions in recipient countries.
Destination Country Registration
Each of the 53 importing countries has specific pharmaceutical registration requirements. Products must be registered with the national drug regulatory authority before customs clearance, regardless of HS code classification.
Need Shipment-Level Data for HS Code 30019099?
Access every individual shipping bill, supplier contacts, buyer details, and pricing trends for products classified under HS Code 30019099.
Shipment Records
456+ individual bills of lading
Verified Suppliers
43 exporters with contact details
Global Coverage
53 importing countries
Frequently Asked Questions — HS Code 30019099
Common questions about HS Code 30019099, answered with data from Indian Customs records.
What is HS code 30019099?
HS code 30019099 refers to "Other glands, organs and substances of human/animal origin" under Chapter 30 (Pharmaceutical Products), Heading 3001 (Glands and organs for organo-therapeutic uses; extracts thereof) of the Harmonized System. In India's export trade, this code covers $10.7M in trade value across 456 shipments from 43 exporters to 53 countries.
What products are exported under HS code 30019099?
11 distinct pharmaceutical products are exported from India under HS code 30019099. The top products include Heparin ($4.1M), Sodium ($3.4M), Chondroitin ($1.7M). These cover a combined trade value of $10.7M.
Which countries import the most under HS code 30019099?
The top importing countries for HS code 30019099 from India are United States ($504.3M), Saudi Arabia ($89.7M), Thailand ($40.2M), Russia ($34.2M), Guatemala ($31.6M). In total, Indian exporters ship products under this code to 53 countries worldwide.
Who are the top Indian exporters under HS code 30019099?
The leading Indian exporters under HS code 30019099 include SANOFI-AVENTIS SINGAPORE PTE LTD ($8.0B), PFIZER SERVICE COMPANY BV ($6.0B), SHANDONG ANXIN PHARMACEUTICAL CO.LTD. ($1.6B). In total, 43 Indian exporters ship products under this classification.
What is the import duty for HS code 30019099?
Import duties for HS code 30019099 (Other glands, organs and substances of human/animal origin) vary by destination country. As a Chapter 30 pharmaceutical product, many countries offer preferential or zero-duty rates for essential medicines under this code. The average transaction value from India is $23.4K, and importers should consult their national customs authority for applicable duty rates, exemptions, and regulatory requirements.
How is HS code 30019099 classified?
HS code 30019099 is an 8-digit Indian Customs Tariff (ITC-HS) code under Chapter 30 (Pharmaceutical Products), Heading 3001 (Glands and organs for organo-therapeutic uses; extracts thereof), Subheading 300190. The first 6 digits follow the international Harmonized System (WCO), while digits 7-8 are India-specific subdivisions used for customs and trade statistics.
What is the trade value of HS code 30019099 from India?
India's total export trade under HS code 30019099 is $10.7M across 456 shipments. The average shipment value is $23.4K. The largest product category is Heparin at $4.1M.
Market Intelligence
Latest developments and market context
Detailed market intelligence for HS Code 30019099 — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
About This Data
Data Methodology
This analysis is compiled from Indian Customs (DGFT) shipping bill records covering the period 2020–2024. Each record includes the declared 8-digit ITC-HS code, product description, trade value (FOB USD), supplier name, buyer name, and destination country. Data is aggregated across all 11 pharmaceutical products classified under HS Code 30019099.
456
Shipment Records
11
Products
2020–2024
Data Coverage
Mar 2026
Last Updated
Disclaimer: Trade data is sourced from publicly available Indian Customs records. Values represent FOB (Free On Board) prices in USD. Actual import values may differ due to CIF adjustments, currency fluctuations, and destination country customs valuation methods.
Classification Details
Top Buyers
Top Importing Countries
Products Using This Code
Official References & Regulatory Resources
HS code classifications follow the WCO Harmonized System. Verify tariff rates with your national customs authority.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.HS Code Classification: HS Code 30019099 (Other glands, organs and substances of human/animal origin) identified under Chapter 30 (Pharmaceutical Products), Heading 3001.
- 2.Product Categorization: 11 pharmaceutical products mapped to this HS code using DGFT product description matching and Indian Customs tariff classification.
- 3.Trade Value Aggregation: Total trade value of $10.7M aggregated from 456 individual shipping bill records across 43 exporters.
- 4.Country Breakdown: Exports distributed across 53 destination countries, with market share calculated per country based on FOB values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
11 Products Under This Code
43 exporters to 53 countries
Expert-Reviewed
By pharmaceutical trade specialists
Enterprise Trade Intelligence
Unlock shipment-level data, supplier contacts, and custom reports for HS Code 30019099.
Request Demo